Genome Web Breaking News
- CRISPR Researchers Develop System to Catalog Wide Range of Gene Editing Outcomes
- Roche Ending Partnership With Syapse
- NIH Seeks Applications to Continue All of Us Program Technical Support Center
- People in the News: Philip Lambert, Peter Bauer, Serafim Batzoglou, Lawrence Weiss, Mike Ward
- In Brief This Week: Foundation Medicine, PerkinElmer, Enzo Biochem, and More
Stat
- STAT Plus: Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version
- STAT Plus: New data show Bluebird, Bristol CAR-T drug could be pioneering myeloma therapy. Competitors may be close behind
- STAT Plus: Lawmakers ask HHS for greater oversight of patient assistance programs
- Revamped, bipartisan Senate package takes aim at drug prices — and props up other health programs, too
- Opinion: Aducanumab: the beginning of the end of Alzheimer’s disease?
Xconomy news
- 3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug
- Duke’s Jacob Jacobsen Joins Evecxia as Chief Scientific Officer
- Akcea Therapeutics Appoints Alex Howarth Chief Operating Officer
- Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
- FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal
Fierce Biotech
- ADDF's Diagnostics Accelerator announces 6 more award-winning Alzheimer's projects
- Novartis posts more phase 3 data as EMA reviews asthma combo
- Hopkins team invents non-viral system for getting gene therapy into cells
- Takeda to develop home hemophilia bleeding risk test with Enzyre
- UCB's bispecific outshines AbbVie's Humira in phase 3 psoriasis test
Fierce Medical Devices
- ADDF's Diagnostics Accelerator announces 6 more award-winning Alzheimer's projects
- Takeda to develop home hemophilia bleeding risk test with Enzyre
- Foundation Medicine nabs 19th companion Dx approval, for Novartis’ aspiring breast cancer blockbuster Piqray
- Spatial tissue analysis developer Akoya nets $50M in funding
- Sight Diagnostics' finger prick blood tester wins FDA clearance